The scientist’s investigation covers issues in Genetics, Pathology, Mutation, Parkinsonism and Parkinson's disease. His work on Genetics is being expanded to include thematically relevant topics such as Ataxia. His Mutation research is multidisciplinary, relying on both Cotton wool plaques, Presenilin and Cell biology.
His research investigates the connection with Parkinsonism and areas like Dystonia which intersect with concerns in Infantile neuroaxonal dystrophy and Exome sequencing. As a part of the same scientific family, he mostly works in the field of Parkinson's disease, focusing on Genome-wide association study and, on occasion, Meta-analysis, LRRK2 and Allele frequency. His research integrates issues of Molecular biology and Frontotemporal dementia and parkinsonism linked to chromosome 17 in his study of Exon.
His primary scientific interests are in Genetics, Pathology, Mutation, Disease and Neuroscience. His works in Gene, Phenotype, Missense mutation, Exome sequencing and Genetic heterogeneity are all subjects of inquiry into Genetics. His study in Atrophy, Parkinsonism, Dementia, Neurodegeneration with brain iron accumulation and Frontotemporal dementia is carried out as part of his studies in Pathology.
His work in Mutation is not limited to one particular discipline; it also encompasses Exon. Henry Houlden is involved in the study of Disease that focuses on Parkinson's disease in particular. Henry Houlden integrates many fields, such as Neuroscience and Clinical neurology, in his works.
His scientific interests lie mostly in Genetics, Disease, Internal medicine, Exome sequencing and Phenotype. Genetics is represented through his Missense mutation, Allele, Gene, Sanger sequencing and Exome research. His Disease research includes themes of Computational biology, Intellectual disability, Bioinformatics and Genetic architecture.
The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine. Atrophy is a subfield of Pathology that Henry Houlden explores. His Pathology research focuses on Cerebellar ataxia and how it relates to Pediatrics and Hypotonia.
Henry Houlden focuses on Genetics, Internal medicine, Cerebellar ataxia, Pathology and Allele. Phenotype, Missense mutation, Haplotype, Microcephaly and Intron are the primary areas of interest in his Genetics study. While the research belongs to areas of Internal medicine, Henry Houlden spends his time largely on the problem of Endocrinology, intersecting his research to questions surrounding Hypotonia, Congenital myasthenic syndrome, Neuromuscular junction and Weakness.
His Cerebellar ataxia study incorporates themes from Cerebellum, Molecular biology and Trinucleotide repeat expansion. His work on Atrophy, Cognitive decline and Calcification as part of general Pathology research is frequently linked to Fragile X-associated tremor/ataxia syndrome, bridging the gap between disciplines. His Allele study integrates concerns from other disciplines, such as Odds ratio, Hyperintensity, Genetic predisposition, Gastroenterology and Genetic association.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
M. Hutton;C. L. Lendon;P. Rizzu;M. Baker.
Nature (1998)
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.
Mike Mullan;Fiona Crawford;Karin Axelman;Henry Houlden.
Nature Genetics (1992)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez;Claudia Schulte;Jose M Bras;Jose M Bras;Manu Sharma.
Nature Genetics (2009)
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Marie Christine Chartier-Harlin;Fiona Crawford;Henry Houlden;Andrew Warren.
Nature (1991)
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie;Alan E. Renton;Kin Mok;Elise G. P. Dopper;Elise G. P. Dopper.
Lancet Neurology (2012)
Association of an extended haplotype in the tau gene with progressive supranuclear palsy.
Matt Baker;Irene Litvan;Henry Houlden;Jennifer Adamson.
Human Molecular Genetics (1999)
A common polymorphism in the brain‐derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS
Binith Cheeran;Penelope Talelli;Francesco Mori;Francesco Mori;Giacomo Koch;Giacomo Koch.
The Journal of Physiology (2008)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease
Mike A. Nalls;Nathan Pankratz;Christina M. Lill;Chuong B. Do.
PMC (2014)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann;Jose Bras;Jose Bras;Emma Deas;Sean S. O'Sullivan.
Brain (2009)
Characterization of PLA2G6 as a locus for dystonia-parkinsonism.
Coro Paisan‐Ruiz;Coro Paisan‐Ruiz;Kailash P. Bhatia;Kailash P. Bhatia;Abi Li;Dena Hernandez.
Annals of Neurology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University College London
University College London
University College London
University College London
University College London
University College London
University College London
National Institutes of Health
University College London
University College London
Hong Kong University of Science and Technology
Aalto University
University of Florida
Tianjin University of Science and Technology
University of Ulm
ExxonMobil (United States)
Indian Institute of Science
Ben-Gurion University of the Negev
Stanford University
University of Queensland
Federal University of Toulouse Midi-Pyrénées
MIT
Stanford University
Imperial College London
Mayo Clinic
Max Planck Society